Author:
Yeung Timothy,Dagan Misha,Lankaputhra Malanka,Cieslik Luke,Warner Victoria,Leet Angeline,Hare James L.,Bergin Peter,Taylor Andrew J.,Kaye David M.,Patel Hitesh C.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Reference23 articles.
1. Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study;Pollesello;J Biol Chem.,1994
2. Vasodilating mechanisms of levosimendan;Yokoshiki;Cardiovasc Drugs Ther,2003
3. National Heart Foundation of Australia and cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart, lung and circulation;Atherton,2018
4. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur J Heart Fail,2016
5. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure;Yancy;J Am Coll Cardiol,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献